Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-15T08:26:39.901Z Has data issue: false hasContentIssue false

EPA-1616 - EPA Guidance on Tobacco Dependence and Strategies for Smoking Cessation in People with Mental Illness

Published online by Cambridge University Press:  15 April 2020

T. Rüther
Affiliation:
Department of Psychiatry, Ludwig Maximilian University, Munich, Germany
J. Bobes
Affiliation:
Department of Medicine Psychiatry Area, University of Oviedo Centro de Investigación Biomédica en Red de Salud Mental Cibersam, Oviedo, Spain
M. De Hert
Affiliation:
Department Neuroscience KU Leuven, University Psychiatric Centre Catholic University Leuven Campus Kortenberg, Kortenberg, Belgium
T.H. Svensson
Affiliation:
Department of Physiology and Pharmacology Section of Neuropsychopharmacology, Karolinska Institute, Stockholm, Sweden
K. Mann
Affiliation:
Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany
A. Batra
Affiliation:
Department of Psychiatry and Psychotherapy Section for Addiction Medicine and Research, University Hospital of Tübingen, Tübingen, Germany
P. Gorwood
Affiliation:
Sainte-Anne Hospital (CMME), University Paris-Descartes, Paris, France
H.J. Möller
Affiliation:
Department of Psychiatry, Ludwig Maximilian University Munich, Munich, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Tobacco dependence is the most common substance use disorder in adults with mental illness. The prevalence rates for tobacco dependence are two to four times higher in these patients than in the general population. Smoking has a strong, negative influence on the life expectancy and quality of life of mental health patients, and remains the leading preventable cause of death in this group. Despite these statistics, in some countries smokers with mental illness are disadvantaged in receiving intervention and support for their tobacco dependence, which is often overlooked or even tolerated.

The statement from the European Psychiatric Association (EPA) systematically reviews the current evidence on tobacco dependence and withdrawal in patients with mental illness and their treatment. It provides seven recommendations for the core components of diagnostics and treatment in this patient group. These recommendations concern (1) the recording process, (2) the timing of the intervention, (3) counselling specificities, (4) proposed treatments, (5) frequency of contact after stopping, (6) follow-up visits and (7) relapse prevention. They aim to help clinicians improve the care, health and well-being of patients suffering from mental illness.

Type
E03 - e-Poster Oral Session 03: Addiction and Geriatric Psychiatry
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.